Capricor Therapeutics Inc (CAPR)
18.53
-0.05
(-0.27%)
USD |
NASDAQ |
Nov 05, 10:18
Capricor Therapeutics Total Assets (Quarterly): 38.28M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 38.28M |
| March 31, 2024 | 49.44M |
| December 31, 2023 | 58.73M |
| September 30, 2023 | 37.15M |
| June 30, 2023 | 46.01M |
| March 31, 2023 | 53.86M |
| December 31, 2022 | 50.09M |
| September 30, 2022 | 53.93M |
| June 30, 2022 | 58.07M |
| March 31, 2022 | 64.92M |
| December 31, 2021 | 41.33M |
| September 30, 2021 | 43.10M |
| June 30, 2021 | 39.93M |
| March 31, 2021 | 43.54M |
| December 31, 2020 | 34.62M |
| September 30, 2020 | 36.19M |
| June 30, 2020 | 37.13M |
| March 31, 2020 | 14.29M |
| December 31, 2019 | 11.11M |
| September 30, 2019 | 7.907M |
| June 30, 2019 | 7.307M |
| March 31, 2019 | 8.618M |
| December 31, 2018 | 9.247M |
| September 30, 2018 | 12.23M |
| June 30, 2018 | 14.33M |
| Date | Value |
|---|---|
| March 31, 2018 | 15.39M |
| December 31, 2017 | 16.27M |
| September 30, 2017 | 15.79M |
| June 30, 2017 | 14.22M |
| March 31, 2017 | 14.07M |
| December 31, 2016 | 18.75M |
| September 30, 2016 | 24.47M |
| June 30, 2016 | 13.89M |
| March 31, 2016 | 16.98M |
| December 31, 2015 | 16.07M |
| September 30, 2015 | 19.88M |
| June 30, 2015 | 23.69M |
| March 31, 2015 | 27.47M |
| December 31, 2014 | 13.63M |
| September 30, 2014 | 16.28M |
| June 30, 2014 | 18.44M |
| March 31, 2014 | 15.98M |
| December 31, 2013 | 5.538M |
| September 30, 2013 | 0.1144M |
| June 30, 2013 | 0.2948M |
| March 31, 2013 | 0.4153M |
| December 31, 2012 | 5.424M |
| September 30, 2012 | 0.4952M |
| June 30, 2012 | 1.000M |
| March 31, 2012 | 0.716M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.11M
Minimum
Dec 2019
64.92M
Maximum
Mar 2022
42.72M
Average
43.10M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 74.36B |
| ResMed Inc | 7.222B |
| enVVeno Medical Corp | 50.39M |
| Regenxbio Inc | 569.38M |
| AIM ImmunoTech Inc | 15.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.78M |
| Shareholders Equity (Quarterly) | 11.50M |
| Current Ratio | 1.372 |